<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
Discover AGCellerate™ for LVV - a faster option to get your GMP-ready lentiviral vector product   Learn about AGCellerate
Contact Us
Contact Us

Nick McDonald

AGC Biologics and VAR2 Pharmaceuticals Completion of antibody late stage clinical work

1 min read

AGC Biologics Announces Successful Completion of Production of Cancer-Specific Therapeutic Antibody Fragments with Var2 Pharmaceuticals

April 23, 2024 at 8:00 PM
News Press Release
AGC Biologics CBO, Christoph Winterhalter

2 min read

AGC Biologics Strengthens Executive Leadership with Appointment of Dr. Christoph Winterhalter as Chief Business Officer

March 25, 2024 at 8:23 AM
News Press Release
AGC Biologics Dual FDA Approval

2 min read

AGC Biologics to Manufacture First-ever FDA Approved Gene Therapy for Early-onset MLD, Orchard Therapeutics’ Lenmeldy™

March 18, 2024 at 3:04 PM
News Press Release
AGC Biologics new manufacturing facility - Yokohama, Japan

1 min read

AGC Biologics announces plans for New Manufacturing Site in Yokohama Japan

January 4, 2024 at 6:01 AM
News Press Release

2 min read

Research: Protein A Capture Technology Offers 10X Productivity Over Standard Resin Columns for Antibody Purification

December 11, 2023 at 8:23 AM
News Press Release
Immunocore Partnership

1 min read

AGC Biologics to Prepare Late-Phase and Commercial Runs for Immunocore

November 19, 2023 at 9:00 PM
News Press Release
AGC Biologics Milan Under Age of 40 Innovation Award

1 min read

AGC Biologics Milan Honored for Leadership and Innovation

October 31, 2023 at 4:02 PM
News Press Release
AGC Biologics and Medigene sign autologous cell therapy clinical manufacturing agreement

1 min read

AGC Biologics Signs TCR-T Cell Services Agreement to Support Medigene’s New Cell Therapy Product

October 24, 2023 at 7:37 PM
Heildelberg ribbon cutting for grand opening of new expansion for pDNA and mRNA.

1 min read

AGC Biologics Completes pDNA and mRNA Expansion at Heidelberg location

October 12, 2023 at 6:34 AM
News Press Release
AGCellerate for Lentiviral Vectors Graphic

1 min read

AGC Biologics Offers Guaranteed Delivery of at least 1e11 TU of LVV Material in Nine Months

September 14, 2023 at 6:00 AM
News Press Release
1 2 3 4 5 Next